MSB 0.84% $1.47 mesoblast limited

Ann: FDA Grants Revascor Orphan Drug For End Stage CHF With LVADs

  1. lightbulb Created with Sketch. 851
    • Release Date: 24/06/19 09:55
    • Summary: FDA Grants Revascor Orphan Drug For End Stage CHF With LVADs
    • Price Sensitive: Yes
    • Download Document  134.93KB
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.47
Change
-0.013(0.84%)
Mkt cap ! $740.5M
Open High Low Value Volume
$1.49 $1.50 $1.47 $347.4K 234.2K

Buyers (Bids)

No. Vol. Price($)
8 2779 $1.47
 

Sellers (Offers)

Price($) Vol. No.
$1.48 2212 4
View Market Depth
Last update - 12.39pm 24/07/2019 (20 minute delay) ?
(live)
Last
$1.48
  Change
-0.013 ( 0.28 %)
Open High Low Volume
$1.49 $1.50 $1.47 33508
Last updated 12.58pm 24/07/2019 (live) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.